MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Charts
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
6003

600380.SS

Joincare Pharmaceutical Group Industry Co.,Ltd.

$10.05
-0.26
 (-2.52%)
Exchange:  SHH
Market Cap:  18.386B
Shares Outstanding:  1.935B
Delayed data
Calculate 600380.SS Intrinsic Value
5-year outlook →
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Healthcare
Industry:  Drug Manufacturers – Specialty & Generic
   
CEO:  Nanqi Lin
Full Time Employees:  13575
Address: 
Joincare Pharmaceutical Group Building
Shenzhen
GD
518057
CN
Website:  https://www.joincare.com
Joincare Pharmaceutical Group Industry Co., Ltd. is a Chinese enterprise primarily focused on the comprehensive process of researching, developing, producing, and commercializing pharmaceutical and healthcare products within China. The company boasts a broad pharmaceutical portfolio that includes both Western chemical drug preparations, addressing conditions such as respiratory, gastrointestinal, anti-infection, gonadotropic, and psychiatric disorders, as well as traditional Chinese medicines (TCM), with offerings for anti-tumor and cold relief. Beyond finished drugs, Joincare supplies chemical active pharmaceutical ingredients (APIs) and intermediates. Its operations also extend into the diagnostics sector, where it provides specialized reagents and equipment, such as an autoimmunity multiple detection platform and an IgM diagnostic kit. Furthermore, the company markets a range of health and wellness products, exemplified by American ginseng tea and Jingxin menocare essence. Joincare diversifies its business by engaging in the wholesale and retail of personal care items, including skincare products, cosmetics, and various other essential goods. Its products are available in diverse formats, such as hormone tablets, oral liquid formulations, and standard tablets. Established in 1992, Joincare Pharmaceutical Group maintains its principal offices in Shenzhen, China.

Click to read more…

Revenue Segmentation

🔒 You are currently logged out

Login

It’s free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

No earnings call materials on file for this symbol yet.

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue16,646,350.34815,619,480.30615,215,739
Gross Profit10,038,792.3959,520,888.0679,501,416
EBITDA3,837,298.2463,865,603.2584,271,178
Operating Income3,506,565.1733,616,283.7263,465,929
Net Income1,442,779.7221,386,570.1931,335,548

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets36,358,126.25835,718,12935,414,299
Total Liabilities13,718,595.75512,317,98711,046,151
Total Stockholders Equity13,755,901.92414,534,72015,179,567
Total Debt5,213,855.5744,899,6113,834,172
Cash and Cash Equivalents15,691,888.31414,851,97713,610,716

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow3,928,909.6053,636,320.9133,891,842.483
Capital Expenditure-1,130,148.505-979,132.038-767,197.834
Free Cash Flow2,798,761.1072,657,188.8783,124,644.648
Net Income1,442,779.7222,982,745.9872,865,028.877
Net Change in Cash1,162,403.686-498,223.694-3,096,950.583

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2028Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Low)18,490,000Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (High)18,490,000Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Avg)18,490,000Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Low)6,796,146.457Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (High)6,796,146.457Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Avg)6,796,146.457Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Low)1,719,685.820Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (High)1,719,685.820Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Avg)1,719,685.820Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Low)5,916,313.336Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (High)5,916,313.336Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Avg)5,916,313.336Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Avg)0.940Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (High)0.940Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Low)0.940Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated Revenue)1Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated EPS)1Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
  ?P/S
 (TTM)
: 
1.24
?Net Income
 (TTM)
: 
  ?P/E
 (TTM)
: 
14.15
?Enterprise Value
 (TTM)
: 
10.647B  ?EV/FCF
 (TTM)
: 
3.26
?Dividend Yield
 (TTM)
: 
2.19%  ?Payout Ratio
 (TTM)
: 
18.58%
?ROE
 (TTM)
: 
8.72%  ?ROIC
 (TTM)
: 
9%
?Net Debt
 (TTM)
: 
  ?Debt/Equity
 (TTM)
: 
0.33
?P/B
 (TTM)
: 
1.18  ?Current Ratio
 (TTM)
: 
2.37

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Research Access for high/low estimates and the interactive table.

Forward P/E 1YResearch AccessResearch AccessResearch AccessResearch Access
84.04Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.

[intrinsic_calculator]

Common questions about 600380.SS valuation

Is Joincare Pharmaceutical Group Industry Co.,Ltd. (600380.SS) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Joincare Pharmaceutical Group Industry Co.,Ltd. (600380.SS) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is 600380.SS a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether 600380.SS trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is 600380.SS’s P/E ratio?

You can see 600380.SS’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for 600380.SS?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is 600380.SS a good long-term investment?

Whether 600380.SS fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

600380.SS

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

-2.52
MARKETSnap

Trading Metrics:

Open: 10.26   Previous Close: 10.31
Day Low: 10.05   Day High: 10.39
Year Low: 9.08   Year High: 14.21
Price Avg 50: 10.03   Price Avg 200: 11.23
Volume: 12.365M   Average Volume: 15.396M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlist & Portfolio Watchlist & Portfolio
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read